FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2906722012> ?p ?o ?g. }

• W2906722012 endingPage "198" @default.
• W2906722012 startingPage "191" @default.
• W2906722012 abstract "Blood loss from surgical procedures is a major issue worldwide as the demand for blood products is increasing. Tranexamic acid is an antifibrinolytic agent commonly used to reduce intraoperative blood loss.To systematically examine the role of tranexamic acid in reducing intraoperative blood loss and postoperative edema and ecchymosis among patients undergoing primary elective rhinoplasty.A systematic review and meta-analysis was undertaken in an academic medical setting using Medline, Embase, and Google Scholar from inception to June 30, 2018. All references of included articles were screened for potential inclusion. The search was mapped to Medical Subject Headings, and the following terms were used to identify potential articles: reconstruction or rhinoplasty and tranexamic acid or anti-fibrinolysis or antifibrinolysis and bleeding or ecchymosis or bruising or edema or complications.The population of interest consisted of adult patients undergoing primary elective rhinoplasty. The intervention was the use of tranexamic acid. The control group was composed of patients receiving a placebo. Primary outcomes were intraoperative blood loss and postoperative edema and ecchymosis. In vitro or animal studies were excluded, and only English-language articles were included.The PRISMA guidelines were followed, and articles were assessed using the Cochrane Collaboration's tool for assessing risk of bias and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) guidelines. Random-effects meta-analysis was performed to determine the overall effect size.The primary outcomes were intraoperative blood loss and postoperative edema and ecchymosis.Five studies (comprising 332 patients) were included in the qualitative analysis, all of which were randomized clinical trials published within the past 5 years. The mean (SD) patient age was 27 (7) years (age range, 16-42 years), while the mean (SD) sample size was 66 (19) (range, 50-96). Meta-analysis of 4 studies (271 patients) indicated that tranexamic acid treatment resulted in a mean reduction in intraoperative blood loss of -41.6 mL (95% CI, -69.8 to -13.4 mL) compared with controls (P = .004). Three studies indicated that postoperative edema and ecchymosis were reduced with tranexamic acid treatment compared with controls; however, there was no significant difference compared with corticosteroid use. Four studies were considered of high methodological quality, with a low risk of bias. The overall quality of evidence was high.Tranexamic acid has the ability to significantly reduce intraoperative blood loss and postoperative edema and ecchymosis among patients undergoing primary elective rhinoplasty.4." @default.
• W2906722012 created "2019-01-11" @default.
• W2906722012 creator A5007749899 @default.
• W2906722012 creator A5028421895 @default.
• W2906722012 creator A5044055206 @default.
• W2906722012 creator A5054840359 @default.
• W2906722012 date "2019-05-01" @default.
• W2906722012 modified "2023-10-13" @default.
• W2906722012 title "Role of Tranexamic Acid in Reducing Intraoperative Blood Loss and Postoperative Edema and Ecchymosis in Primary Elective Rhinoplasty" @default.
• W2906722012 cites W1889186786 @default.
• W2906722012 cites W1903132268 @default.
• W2906722012 cites W1983583305 @default.
• W2906722012 cites W1993653149 @default.
• W2906722012 cites W2012932483 @default.
• W2906722012 cites W2016016217 @default.
• W2906722012 cites W2018909981 @default.
• W2906722012 cites W2032549859 @default.
• W2906722012 cites W2044571225 @default.
• W2906722012 cites W2055116941 @default.
• W2906722012 cites W2081914277 @default.
• W2906722012 cites W2081917756 @default.
• W2906722012 cites W2084048987 @default.
• W2906722012 cites W2094901845 @default.
• W2906722012 cites W2098923148 @default.
• W2906722012 cites W2107339086 @default.
• W2906722012 cites W2135400982 @default.
• W2906722012 cites W2158392152 @default.
• W2906722012 cites W2170989127 @default.
• W2906722012 cites W2304135101 @default.
• W2906722012 cites W2326271479 @default.
• W2906722012 cites W2330540452 @default.
• W2906722012 cites W2344307631 @default.
• W2906722012 cites W2401641542 @default.
• W2906722012 cites W2401729222 @default.
• W2906722012 cites W2413550491 @default.
• W2906722012 cites W2436799369 @default.
• W2906722012 cites W2465824537 @default.
• W2906722012 cites W2480095255 @default.
• W2906722012 cites W2528520635 @default.
• W2906722012 cites W2539290297 @default.
• W2906722012 cites W2588681363 @default.
• W2906722012 cites W2594895112 @default.
• W2906722012 cites W2598049992 @default.
• W2906722012 cites W2599123742 @default.
• W2906722012 cites W2607870311 @default.
• W2906722012 cites W2730485792 @default.
• W2906722012 cites W2759789986 @default.
• W2906722012 cites W2761153591 @default.
• W2906722012 cites W2770305308 @default.
• W2906722012 cites W3022903699 @default.
• W2906722012 cites W4233944854 @default.
• W2906722012 cites W4292528167 @default.
• W2906722012 cites W2588833713 @default.
• W2906722012 doi "https://doi.org/10.1001/jamafacial.2018.1737" @default.
• W2906722012 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6537831" @default.
• W2906722012 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30605219" @default.
• W2906722012 hasPublicationYear "2019" @default.
• W2906722012 type Work @default.
• W2906722012 sameAs 2906722012 @default.
• W2906722012 citedByCount "33" @default.
• W2906722012 countsByYear W29067220122019 @default.
• W2906722012 countsByYear W29067220122020 @default.
• W2906722012 countsByYear W29067220122021 @default.
• W2906722012 countsByYear W29067220122022 @default.
• W2906722012 countsByYear W29067220122023 @default.
• W2906722012 crossrefType "journal-article" @default.
• W2906722012 hasAuthorship W2906722012A5007749899 @default.
• W2906722012 hasAuthorship W2906722012A5028421895 @default.
• W2906722012 hasAuthorship W2906722012A5044055206 @default.
• W2906722012 hasAuthorship W2906722012A5054840359 @default.
• W2906722012 hasBestOaLocation W29067220121 @default.
• W2906722012 hasConcept C141071460 @default.
• W2906722012 hasConcept C168563851 @default.
• W2906722012 hasConcept C2776050027 @default.
• W2906722012 hasConcept C2778311950 @default.
• W2906722012 hasConcept C2779637338 @default.
• W2906722012 hasConcept C2779663748 @default.
• W2906722012 hasConcept C2780886150 @default.
• W2906722012 hasConcept C2991743468 @default.
• W2906722012 hasConcept C42219234 @default.
• W2906722012 hasConcept C71924100 @default.
• W2906722012 hasConceptScore W2906722012C141071460 @default.
• W2906722012 hasConceptScore W2906722012C168563851 @default.
• W2906722012 hasConceptScore W2906722012C2776050027 @default.
• W2906722012 hasConceptScore W2906722012C2778311950 @default.
• W2906722012 hasConceptScore W2906722012C2779637338 @default.
• W2906722012 hasConceptScore W2906722012C2779663748 @default.
• W2906722012 hasConceptScore W2906722012C2780886150 @default.
• W2906722012 hasConceptScore W2906722012C2991743468 @default.
• W2906722012 hasConceptScore W2906722012C42219234 @default.
• W2906722012 hasConceptScore W2906722012C71924100 @default.
• W2906722012 hasIssue "3" @default.
• W2906722012 hasLocation W29067220121 @default.
• W2906722012 hasLocation W29067220122 @default.
• W2906722012 hasLocation W29067220123 @default.
• W2906722012 hasLocation W29067220124 @default.
• W2906722012 hasOpenAccess W2906722012 @default.
• W2906722012 hasPrimaryLocation W29067220121 @default.

• next